Aluminum-based Vaccine Adjuvant Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Aluminum-based Vaccine Adjuvant in global, including the following market information:
Global Aluminum-based Vaccine Adjuvant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Aluminum-based Vaccine Adjuvant Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Aluminum-based Vaccine Adjuvant companies in 2021 (%)
The global Aluminum-based Vaccine Adjuvant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aluminium Potassium Sulfate Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aluminum-based Vaccine Adjuvant include Emergent BioSolutions, Sanofi, GlaxoSmithKline Biologicals, Pfizer, Merck and Wyeth Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aluminum-based Vaccine Adjuvant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aluminum-based Vaccine Adjuvant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Aluminum-based Vaccine Adjuvant Market Segment Percentages, by Type, 2021 (%)
Global Aluminum-based Vaccine Adjuvant Market Segment Percentages, by Application, 2021 (%)
Global Aluminum-based Vaccine Adjuvant Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Aluminum-based Vaccine Adjuvant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Aluminum-based Vaccine Adjuvant revenues share in global market, 2021 (%)
Key companies Aluminum-based Vaccine Adjuvant sales in global market, 2017-2022 (Estimated), (KG)
Key companies Aluminum-based Vaccine Adjuvant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Aluminum-based Vaccine Adjuvant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Aluminum-based Vaccine Adjuvant Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Aluminum-based Vaccine Adjuvant companies in 2021 (%)
The global Aluminum-based Vaccine Adjuvant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aluminium Potassium Sulfate Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aluminum-based Vaccine Adjuvant include Emergent BioSolutions, Sanofi, GlaxoSmithKline Biologicals, Pfizer, Merck and Wyeth Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aluminum-based Vaccine Adjuvant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aluminum-based Vaccine Adjuvant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Aluminum-based Vaccine Adjuvant Market Segment Percentages, by Type, 2021 (%)
- Aluminium Potassium Sulfate Based
- Aluminum Phosphate Based
- Aluminum Hydroxide Based
Global Aluminum-based Vaccine Adjuvant Market Segment Percentages, by Application, 2021 (%)
- Dtap (diphtheria, Tetanus, Acellular Whooping Cough)
- Human Papillomavirus
- Pneumococcal
- Hepatitis A
- Hepatitis B
- Novel Coronavirus
- Other
Global Aluminum-based Vaccine Adjuvant Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Aluminum-based Vaccine Adjuvant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Aluminum-based Vaccine Adjuvant revenues share in global market, 2021 (%)
Key companies Aluminum-based Vaccine Adjuvant sales in global market, 2017-2022 (Estimated), (KG)
Key companies Aluminum-based Vaccine Adjuvant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Emergent BioSolutions
- Sanofi
- GlaxoSmithKline Biologicals
- Pfizer
- Merck
- Wyeth Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Aluminum-based Vaccine Adjuvant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Aluminum-based Vaccine Adjuvant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ALUMINUM-BASED VACCINE ADJUVANT OVERALL MARKET SIZE
2.1 Global Aluminum-based Vaccine Adjuvant Market Size: 2021 VS 2028
2.2 Global Aluminum-based Vaccine Adjuvant Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Aluminum-based Vaccine Adjuvant Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Aluminum-based Vaccine Adjuvant Players in Global Market
3.2 Top Global Aluminum-based Vaccine Adjuvant Companies Ranked by Revenue
3.3 Global Aluminum-based Vaccine Adjuvant Revenue by Companies
3.4 Global Aluminum-based Vaccine Adjuvant Sales by Companies
3.5 Global Aluminum-based Vaccine Adjuvant Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Aluminum-based Vaccine Adjuvant Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Aluminum-based Vaccine Adjuvant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Aluminum-based Vaccine Adjuvant Players in Global Market
3.8.1 List of Global Tier 1 Aluminum-based Vaccine Adjuvant Companies
3.8.2 List of Global Tier 2 and Tier 3 Aluminum-based Vaccine Adjuvant Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Aluminum-based Vaccine Adjuvant Market Size Markets, 2021 & 2028
4.1.2 Aluminium Potassium Sulfate Based
4.1.3 Aluminum Phosphate Based
4.1.4 Aluminum Hydroxide Based
4.2 By Type - Global Aluminum-based Vaccine Adjuvant Revenue & Forecasts
4.2.1 By Type - Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2022
4.2.2 By Type - Global Aluminum-based Vaccine Adjuvant Revenue, 2023-2028
4.2.3 By Type - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
4.3 By Type - Global Aluminum-based Vaccine Adjuvant Sales & Forecasts
4.3.1 By Type - Global Aluminum-based Vaccine Adjuvant Sales, 2017-2022
4.3.2 By Type - Global Aluminum-based Vaccine Adjuvant Sales, 2023-2028
4.3.3 By Type - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
4.4 By Type - Global Aluminum-based Vaccine Adjuvant Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Aluminum-based Vaccine Adjuvant Market Size, 2021 & 2028
5.1.2 Dtap (diphtheria, Tetanus, Acellular Whooping Cough)
5.1.3 Human Papillomavirus
5.1.4 Pneumococcal
5.1.5 Hepatitis A
5.1.6 Hepatitis B
5.1.7 Novel Coronavirus
5.1.8 Other
5.2 By Application - Global Aluminum-based Vaccine Adjuvant Revenue & Forecasts
5.2.1 By Application - Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2022
5.2.2 By Application - Global Aluminum-based Vaccine Adjuvant Revenue, 2023-2028
5.2.3 By Application - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
5.3 By Application - Global Aluminum-based Vaccine Adjuvant Sales & Forecasts
5.3.1 By Application - Global Aluminum-based Vaccine Adjuvant Sales, 2017-2022
5.3.2 By Application - Global Aluminum-based Vaccine Adjuvant Sales, 2023-2028
5.3.3 By Application - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
5.4 By Application - Global Aluminum-based Vaccine Adjuvant Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Aluminum-based Vaccine Adjuvant Market Size, 2021 & 2028
6.2 By Region - Global Aluminum-based Vaccine Adjuvant Revenue & Forecasts
6.2.1 By Region - Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2022
6.2.2 By Region - Global Aluminum-based Vaccine Adjuvant Revenue, 2023-2028
6.2.3 By Region - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
6.3 By Region - Global Aluminum-based Vaccine Adjuvant Sales & Forecasts
6.3.1 By Region - Global Aluminum-based Vaccine Adjuvant Sales, 2017-2022
6.3.2 By Region - Global Aluminum-based Vaccine Adjuvant Sales, 2023-2028
6.3.3 By Region - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.4.2 By Country - North America Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.4.3 US Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.4.4 Canada Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.4.5 Mexico Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.5.2 By Country - Europe Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.5.3 Germany Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.4 France Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.5 U.K. Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.6 Italy Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.7 Russia Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.8 Nordic Countries Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.9 Benelux Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.6.2 By Region - Asia Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.6.3 China Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.4 Japan Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.5 South Korea Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.6 Southeast Asia Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.7 India Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.7.2 By Country - South America Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.7.3 Brazil Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.7.4 Argentina Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.8.3 Turkey Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8.4 Israel Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8.5 Saudi Arabia Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8.6 UAE Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Emergent BioSolutions
7.1.1 Emergent BioSolutions Corporate Summary
7.1.2 Emergent BioSolutions Business Overview
7.1.3 Emergent BioSolutions Aluminum-based Vaccine Adjuvant Major Product Offerings
7.1.4 Emergent BioSolutions Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.1.5 Emergent BioSolutions Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Aluminum-based Vaccine Adjuvant Major Product Offerings
7.2.4 Sanofi Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 GlaxoSmithKline Biologicals
7.3.1 GlaxoSmithKline Biologicals Corporate Summary
7.3.2 GlaxoSmithKline Biologicals Business Overview
7.3.3 GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Major Product Offerings
7.3.4 GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Biologicals Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Aluminum-based Vaccine Adjuvant Major Product Offerings
7.4.4 Pfizer Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Aluminum-based Vaccine Adjuvant Major Product Offerings
7.5.4 Merck Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.5.5 Merck Key News
7.6 Wyeth Pharmaceuticals
7.6.1 Wyeth Pharmaceuticals Corporate Summary
7.6.2 Wyeth Pharmaceuticals Business Overview
7.6.3 Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Major Product Offerings
7.6.4 Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.6.5 Wyeth Pharmaceuticals Key News
8 GLOBAL ALUMINUM-BASED VACCINE ADJUVANT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Aluminum-based Vaccine Adjuvant Production Capacity, 2017-2028
8.2 Aluminum-based Vaccine Adjuvant Production Capacity of Key Manufacturers in Global Market
8.3 Global Aluminum-based Vaccine Adjuvant Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ALUMINUM-BASED VACCINE ADJUVANT SUPPLY CHAIN ANALYSIS
10.1 Aluminum-based Vaccine Adjuvant Industry Value Chain
10.2 Aluminum-based Vaccine Adjuvant Upstream Market
10.3 Aluminum-based Vaccine Adjuvant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Aluminum-based Vaccine Adjuvant Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Aluminum-based Vaccine Adjuvant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Aluminum-based Vaccine Adjuvant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ALUMINUM-BASED VACCINE ADJUVANT OVERALL MARKET SIZE
2.1 Global Aluminum-based Vaccine Adjuvant Market Size: 2021 VS 2028
2.2 Global Aluminum-based Vaccine Adjuvant Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Aluminum-based Vaccine Adjuvant Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Aluminum-based Vaccine Adjuvant Players in Global Market
3.2 Top Global Aluminum-based Vaccine Adjuvant Companies Ranked by Revenue
3.3 Global Aluminum-based Vaccine Adjuvant Revenue by Companies
3.4 Global Aluminum-based Vaccine Adjuvant Sales by Companies
3.5 Global Aluminum-based Vaccine Adjuvant Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Aluminum-based Vaccine Adjuvant Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Aluminum-based Vaccine Adjuvant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Aluminum-based Vaccine Adjuvant Players in Global Market
3.8.1 List of Global Tier 1 Aluminum-based Vaccine Adjuvant Companies
3.8.2 List of Global Tier 2 and Tier 3 Aluminum-based Vaccine Adjuvant Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Aluminum-based Vaccine Adjuvant Market Size Markets, 2021 & 2028
4.1.2 Aluminium Potassium Sulfate Based
4.1.3 Aluminum Phosphate Based
4.1.4 Aluminum Hydroxide Based
4.2 By Type - Global Aluminum-based Vaccine Adjuvant Revenue & Forecasts
4.2.1 By Type - Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2022
4.2.2 By Type - Global Aluminum-based Vaccine Adjuvant Revenue, 2023-2028
4.2.3 By Type - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
4.3 By Type - Global Aluminum-based Vaccine Adjuvant Sales & Forecasts
4.3.1 By Type - Global Aluminum-based Vaccine Adjuvant Sales, 2017-2022
4.3.2 By Type - Global Aluminum-based Vaccine Adjuvant Sales, 2023-2028
4.3.3 By Type - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
4.4 By Type - Global Aluminum-based Vaccine Adjuvant Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Aluminum-based Vaccine Adjuvant Market Size, 2021 & 2028
5.1.2 Dtap (diphtheria, Tetanus, Acellular Whooping Cough)
5.1.3 Human Papillomavirus
5.1.4 Pneumococcal
5.1.5 Hepatitis A
5.1.6 Hepatitis B
5.1.7 Novel Coronavirus
5.1.8 Other
5.2 By Application - Global Aluminum-based Vaccine Adjuvant Revenue & Forecasts
5.2.1 By Application - Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2022
5.2.2 By Application - Global Aluminum-based Vaccine Adjuvant Revenue, 2023-2028
5.2.3 By Application - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
5.3 By Application - Global Aluminum-based Vaccine Adjuvant Sales & Forecasts
5.3.1 By Application - Global Aluminum-based Vaccine Adjuvant Sales, 2017-2022
5.3.2 By Application - Global Aluminum-based Vaccine Adjuvant Sales, 2023-2028
5.3.3 By Application - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
5.4 By Application - Global Aluminum-based Vaccine Adjuvant Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Aluminum-based Vaccine Adjuvant Market Size, 2021 & 2028
6.2 By Region - Global Aluminum-based Vaccine Adjuvant Revenue & Forecasts
6.2.1 By Region - Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2022
6.2.2 By Region - Global Aluminum-based Vaccine Adjuvant Revenue, 2023-2028
6.2.3 By Region - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
6.3 By Region - Global Aluminum-based Vaccine Adjuvant Sales & Forecasts
6.3.1 By Region - Global Aluminum-based Vaccine Adjuvant Sales, 2017-2022
6.3.2 By Region - Global Aluminum-based Vaccine Adjuvant Sales, 2023-2028
6.3.3 By Region - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.4.2 By Country - North America Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.4.3 US Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.4.4 Canada Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.4.5 Mexico Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.5.2 By Country - Europe Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.5.3 Germany Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.4 France Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.5 U.K. Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.6 Italy Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.7 Russia Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.8 Nordic Countries Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.5.9 Benelux Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.6.2 By Region - Asia Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.6.3 China Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.4 Japan Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.5 South Korea Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.6 Southeast Asia Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.6.7 India Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.7.2 By Country - South America Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.7.3 Brazil Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.7.4 Argentina Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales, 2017-2028
6.8.3 Turkey Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8.4 Israel Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8.5 Saudi Arabia Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
6.8.6 UAE Aluminum-based Vaccine Adjuvant Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Emergent BioSolutions
7.1.1 Emergent BioSolutions Corporate Summary
7.1.2 Emergent BioSolutions Business Overview
7.1.3 Emergent BioSolutions Aluminum-based Vaccine Adjuvant Major Product Offerings
7.1.4 Emergent BioSolutions Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.1.5 Emergent BioSolutions Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Aluminum-based Vaccine Adjuvant Major Product Offerings
7.2.4 Sanofi Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 GlaxoSmithKline Biologicals
7.3.1 GlaxoSmithKline Biologicals Corporate Summary
7.3.2 GlaxoSmithKline Biologicals Business Overview
7.3.3 GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Major Product Offerings
7.3.4 GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Biologicals Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Aluminum-based Vaccine Adjuvant Major Product Offerings
7.4.4 Pfizer Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Aluminum-based Vaccine Adjuvant Major Product Offerings
7.5.4 Merck Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.5.5 Merck Key News
7.6 Wyeth Pharmaceuticals
7.6.1 Wyeth Pharmaceuticals Corporate Summary
7.6.2 Wyeth Pharmaceuticals Business Overview
7.6.3 Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Major Product Offerings
7.6.4 Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Sales and Revenue in Global (2017-2022)
7.6.5 Wyeth Pharmaceuticals Key News
8 GLOBAL ALUMINUM-BASED VACCINE ADJUVANT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Aluminum-based Vaccine Adjuvant Production Capacity, 2017-2028
8.2 Aluminum-based Vaccine Adjuvant Production Capacity of Key Manufacturers in Global Market
8.3 Global Aluminum-based Vaccine Adjuvant Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ALUMINUM-BASED VACCINE ADJUVANT SUPPLY CHAIN ANALYSIS
10.1 Aluminum-based Vaccine Adjuvant Industry Value Chain
10.2 Aluminum-based Vaccine Adjuvant Upstream Market
10.3 Aluminum-based Vaccine Adjuvant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Aluminum-based Vaccine Adjuvant Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Aluminum-based Vaccine Adjuvant in Global Market
Table 2. Top Aluminum-based Vaccine Adjuvant Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Aluminum-based Vaccine Adjuvant Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Aluminum-based Vaccine Adjuvant Revenue Share by Companies, 2017-2022
Table 5. Global Aluminum-based Vaccine Adjuvant Sales by Companies, (KG), 2017-2022
Table 6. Global Aluminum-based Vaccine Adjuvant Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Aluminum-based Vaccine Adjuvant Price (2017-2022) & (US$/KG)
Table 8. Global Manufacturers Aluminum-based Vaccine Adjuvant Product Type
Table 9. List of Global Tier 1 Aluminum-based Vaccine Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Aluminum-based Vaccine Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2017-2022
Table 15. By Type - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2023-2028
Table 16. By Application – Global Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2017-2022
Table 20. By Application - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2023-2028
Table 21. By Region – Global Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2017-2022
Table 25. By Region - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2023-2028
Table 26. By Country - North America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 29. By Country - North America Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 30. By Country - Europe Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 33. By Country - Europe Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 34. By Region - Asia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 37. By Region - Asia Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 38. By Country - South America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 41. By Country - South America Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 46. Emergent BioSolutions Corporate Summary
Table 47. Emergent BioSolutions Aluminum-based Vaccine Adjuvant Product Offerings
Table 48. Emergent BioSolutions Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Aluminum-based Vaccine Adjuvant Product Offerings
Table 51. Sanofi Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 52. GlaxoSmithKline Biologicals Corporate Summary
Table 53. GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Product Offerings
Table 54. GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Aluminum-based Vaccine Adjuvant Product Offerings
Table 57. Pfizer Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 58. Merck Corporate Summary
Table 59. Merck Aluminum-based Vaccine Adjuvant Product Offerings
Table 60. Merck Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 61. Wyeth Pharmaceuticals Corporate Summary
Table 62. Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Product Offerings
Table 63. Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 64. Aluminum-based Vaccine Adjuvant Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 65. Global Aluminum-based Vaccine Adjuvant Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Aluminum-based Vaccine Adjuvant Production by Region, 2017-2022 (KG)
Table 67. Global Aluminum-based Vaccine Adjuvant Production by Region, 2023-2028 (KG)
Table 68. Aluminum-based Vaccine Adjuvant Market Opportunities & Trends in Global Market
Table 69. Aluminum-based Vaccine Adjuvant Market Drivers in Global Market
Table 70. Aluminum-based Vaccine Adjuvant Market Restraints in Global Market
Table 71. Aluminum-based Vaccine Adjuvant Raw Materials
Table 72. Aluminum-based Vaccine Adjuvant Raw Materials Suppliers in Global Market
Table 73. Typical Aluminum-based Vaccine Adjuvant Downstream
Table 74. Aluminum-based Vaccine Adjuvant Downstream Clients in Global Market
Table 75. Aluminum-based Vaccine Adjuvant Distributors and Sales Agents in Global Market
Table 1. Key Players of Aluminum-based Vaccine Adjuvant in Global Market
Table 2. Top Aluminum-based Vaccine Adjuvant Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Aluminum-based Vaccine Adjuvant Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Aluminum-based Vaccine Adjuvant Revenue Share by Companies, 2017-2022
Table 5. Global Aluminum-based Vaccine Adjuvant Sales by Companies, (KG), 2017-2022
Table 6. Global Aluminum-based Vaccine Adjuvant Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Aluminum-based Vaccine Adjuvant Price (2017-2022) & (US$/KG)
Table 8. Global Manufacturers Aluminum-based Vaccine Adjuvant Product Type
Table 9. List of Global Tier 1 Aluminum-based Vaccine Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Aluminum-based Vaccine Adjuvant Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2017-2022
Table 15. By Type - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2023-2028
Table 16. By Application – Global Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2017-2022
Table 20. By Application - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2023-2028
Table 21. By Region – Global Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Aluminum-based Vaccine Adjuvant Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2017-2022
Table 25. By Region - Global Aluminum-based Vaccine Adjuvant Sales (KG), 2023-2028
Table 26. By Country - North America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 29. By Country - North America Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 30. By Country - Europe Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 33. By Country - Europe Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 34. By Region - Asia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 37. By Region - Asia Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 38. By Country - South America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 41. By Country - South America Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales, (KG), 2023-2028
Table 46. Emergent BioSolutions Corporate Summary
Table 47. Emergent BioSolutions Aluminum-based Vaccine Adjuvant Product Offerings
Table 48. Emergent BioSolutions Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Aluminum-based Vaccine Adjuvant Product Offerings
Table 51. Sanofi Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 52. GlaxoSmithKline Biologicals Corporate Summary
Table 53. GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Product Offerings
Table 54. GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Aluminum-based Vaccine Adjuvant Product Offerings
Table 57. Pfizer Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 58. Merck Corporate Summary
Table 59. Merck Aluminum-based Vaccine Adjuvant Product Offerings
Table 60. Merck Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 61. Wyeth Pharmaceuticals Corporate Summary
Table 62. Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Product Offerings
Table 63. Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Sales (KG), Revenue (US$, Mn) and Average Price (US$/KG) (2017-2022)
Table 64. Aluminum-based Vaccine Adjuvant Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 65. Global Aluminum-based Vaccine Adjuvant Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Aluminum-based Vaccine Adjuvant Production by Region, 2017-2022 (KG)
Table 67. Global Aluminum-based Vaccine Adjuvant Production by Region, 2023-2028 (KG)
Table 68. Aluminum-based Vaccine Adjuvant Market Opportunities & Trends in Global Market
Table 69. Aluminum-based Vaccine Adjuvant Market Drivers in Global Market
Table 70. Aluminum-based Vaccine Adjuvant Market Restraints in Global Market
Table 71. Aluminum-based Vaccine Adjuvant Raw Materials
Table 72. Aluminum-based Vaccine Adjuvant Raw Materials Suppliers in Global Market
Table 73. Typical Aluminum-based Vaccine Adjuvant Downstream
Table 74. Aluminum-based Vaccine Adjuvant Downstream Clients in Global Market
Table 75. Aluminum-based Vaccine Adjuvant Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Aluminum-based Vaccine Adjuvant Segment by Type
Figure 2. Aluminum-based Vaccine Adjuvant Segment by Application
Figure 3. Global Aluminum-based Vaccine Adjuvant Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Aluminum-based Vaccine Adjuvant Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2028 (US$, Mn)
Figure 7. Aluminum-based Vaccine Adjuvant Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Aluminum-based Vaccine Adjuvant Revenue in 2021
Figure 9. By Type - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 10. By Type - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 11. By Type - Global Aluminum-based Vaccine Adjuvant Price (US$/KG), 2017-2028
Figure 12. By Application - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 13. By Application - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 14. By Application - Global Aluminum-based Vaccine Adjuvant Price (US$/KG), 2017-2028
Figure 15. By Region - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 16. By Region - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 17. By Country - North America Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 18. By Country - North America Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 19. US Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 24. Germany Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 25. France Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 33. China Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 37. India Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 39. By Country - South America Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 40. Brazil Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 44. Turkey Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 48. Global Aluminum-based Vaccine Adjuvant Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Aluminum-based Vaccine Adjuvant by Region, 2021 VS 2028
Figure 50. Aluminum-based Vaccine Adjuvant Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Aluminum-based Vaccine Adjuvant Segment by Type
Figure 2. Aluminum-based Vaccine Adjuvant Segment by Application
Figure 3. Global Aluminum-based Vaccine Adjuvant Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Aluminum-based Vaccine Adjuvant Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Aluminum-based Vaccine Adjuvant Revenue, 2017-2028 (US$, Mn)
Figure 7. Aluminum-based Vaccine Adjuvant Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Aluminum-based Vaccine Adjuvant Revenue in 2021
Figure 9. By Type - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 10. By Type - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 11. By Type - Global Aluminum-based Vaccine Adjuvant Price (US$/KG), 2017-2028
Figure 12. By Application - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 13. By Application - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 14. By Application - Global Aluminum-based Vaccine Adjuvant Price (US$/KG), 2017-2028
Figure 15. By Region - Global Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 16. By Region - Global Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 17. By Country - North America Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 18. By Country - North America Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 19. US Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 24. Germany Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 25. France Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 33. China Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 37. India Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 39. By Country - South America Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 40. Brazil Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Aluminum-based Vaccine Adjuvant Sales Market Share, 2017-2028
Figure 44. Turkey Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Aluminum-based Vaccine Adjuvant Revenue, (US$, Mn), 2017-2028
Figure 48. Global Aluminum-based Vaccine Adjuvant Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Aluminum-based Vaccine Adjuvant by Region, 2021 VS 2028
Figure 50. Aluminum-based Vaccine Adjuvant Industry Value Chain
Figure 51. Marketing Channels
